Skip to content

TENAX THERAPEUTICS, INC.: 10-Q filed 2014-03-17

What TENAX THERAPEUTICS, INC. reported in its quarterly report filed 2014-03-17 (fiscal Q3 2014): 42 published measures, 135 facts as tagged in accession 0001354488-14-001188.

This filing

Form
10-Q (quarterly report)
Filed
2014-03-17
Fiscal period
fiscal Q3 2014
Accession
0001354488-14-001188 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TENAX THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-01-3133,936,209USD
At 2013-04-303,180,643USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-01-313,635,442USD
At 2013-04-304,958,679USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-01-3130,300,767USD
At 2013-04-30-1,778,036USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-01-316,339,657USD
At 2013-04-30783,528USD
At 2013-01-31828,811USD
At 2012-04-301,879,872USD
At 1967-08-250USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-11-01 to 2014-01-31-3,350,921USD92
2013-05-01 to 2014-01-31-9,127,680USD276
1967-08-26 to 2014-01-31-126,619,252USD16961
2012-11-01 to 2013-01-31-2,412,954USD92
2012-05-01 to 2013-01-31-7,556,774USD276

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-05-01 to 2014-01-31-6,281,653USD276
1967-08-26 to 2014-01-31-63,503,488USD16961
2012-05-01 to 2013-01-31-3,480,825USD276

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-05-01 to 2014-01-319,804USD276
1967-08-26 to 2014-01-311,788,746USD16961
2012-05-01 to 2013-01-3114,932USD276

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-11-01 to 2014-01-3141,864USD92
2013-05-01 to 2014-01-31263,375USD276
1967-08-26 to 2014-01-311,929,604USD16961
2012-11-01 to 2013-01-31222,388USD92
2012-05-01 to 2013-01-311,009,356USD276

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-05-01 to 2014-01-3111,950,826USD276
1967-08-26 to 2014-01-3173,623,752USD16961
2012-05-01 to 2013-01-312,535,699USD276

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-05-01 to 2014-01-31-113,044USD276
1967-08-26 to 2014-01-31-3,780,607USD16961
2012-05-01 to 2013-01-31-105,935USD276

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-01-31-126,171,764USD
At 2013-04-30-117,044,084USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-11-01 to 2014-01-3110,260,021shares92
2013-05-01 to 2014-01-315,811,162shares276
2012-11-01 to 2013-01-311,658,895shares92
2012-05-01 to 2013-01-311,591,438shares276

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-11-01 to 2014-01-3110,266,601shares92
2013-05-01 to 2014-01-315,817,819shares276
2012-11-01 to 2013-01-311,767,640shares92
2012-05-01 to 2013-01-311,700,183shares276

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-11-01 to 2014-01-31-0.43USD/shares92
2013-05-01 to 2014-01-31-2.56USD/shares276
2012-11-01 to 2013-01-31-1.45USD/shares92
2012-05-01 to 2013-01-31-4.75USD/shares276

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-11-01 to 2014-01-31-0.44USD/shares92
2013-05-01 to 2014-01-31-2.58USD/shares276
2012-11-01 to 2013-01-31-2.78USD/shares92
2012-05-01 to 2013-01-31-5.91USD/shares276

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-01-31149,365USD
At 2013-04-30205,389USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-05-01 to 2014-01-31253,502USD276
1967-08-26 to 2014-01-311,121,292USD16961
2012-05-01 to 2013-01-31169,294USD276

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-11-01 to 2014-01-31-2,431,398USD92
2013-05-01 to 2014-01-31-6,135,271USD276
1967-08-26 to 2014-01-31-80,197,067USD16961
2012-11-01 to 2013-01-31-1,591,500USD92
2012-05-01 to 2013-01-31-3,949,785USD276

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-01-317,389,466USD
At 2013-04-301,842,251USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-11-01 to 2014-01-3169,967USD92
2013-05-01 to 2014-01-312,142,627USD276
1967-08-26 to 2014-01-3146,104,646USD16961
2012-11-01 to 2013-01-31821,777USD92
2012-05-01 to 2013-01-313,615,204USD276

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-01-313,613,578USD
At 2013-04-301,909,577USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-01-31668,671USD
At 2013-04-30977,162USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-01-313,303,000USD
At 2013-04-300USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-01-3122,982,535USD
At 2013-04-30924,698USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-01-3153,106USD
At 2013-04-30445,237USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-11-01 to 2014-01-312,473,262USD92
2013-05-01 to 2014-01-316,398,646USD276
1967-08-26 to 2014-01-3182,126,671USD16961
2012-11-01 to 2013-01-311,813,888USD92
2012-05-01 to 2013-01-314,959,141USD276

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-01-3197,437USD
At 2013-04-3099,204USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-11-01 to 2014-01-31180USD92
2013-05-01 to 2014-01-3129,394USD276
1967-08-26 to 2014-01-31239,752USD16961
2012-11-01 to 2013-01-311,337USD92
2012-05-01 to 2013-01-3112,321USD276

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-11-01 to 2014-01-311,783,596USD92
2013-05-01 to 2014-01-314,187,522USD276
1967-08-26 to 2014-01-3154,772,734USD16961
2012-11-01 to 2013-01-311,441,500USD92
2012-05-01 to 2013-01-313,127,133USD276

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-11-01 to 2014-01-31689,666USD92
2013-05-01 to 2014-01-312,211,124USD276
1967-08-26 to 2014-01-3126,742,252USD16961
2012-11-01 to 2013-01-31369,447USD92
2012-05-01 to 2013-01-311,611,293USD276

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-01-316,814,293shares
At 2013-04-301,930,078shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-01-311,042,559USD
At 2013-04-301,034,141USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-01-31-893,194USD
At 2013-04-30-828,752USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-01-3122,982,535USD
At 2013-04-30924,698USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-01-3158,262USD
At 2013-04-3058,262USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-01-3121,864USD
At 2013-04-3054,660USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-01-311,493,198USD
At 2013-04-30874,876USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-11-01 to 2014-01-314,446,743USD92
2013-05-01 to 2014-01-3114,869,842USD276
1967-08-26 to 2014-01-31133,319,485USD16961
2012-11-01 to 2013-01-312,412,954USD92
2012-05-01 to 2013-01-317,556,774USD276

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-11-01 to 2014-01-3121,000USD92
2013-05-01 to 2014-01-3166,000USD276
2012-11-01 to 2013-01-3123,000USD92
2012-05-01 to 2013-01-3170,000USD276

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-11-01 to 2014-01-3116,000USD92
2013-05-01 to 2014-01-3145,000USD276
2012-11-01 to 2013-01-3114,000USD92
2012-05-01 to 2013-01-3141,000USD276

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-11-01 to 2014-01-31-849,556USD92
2013-05-01 to 2014-01-31-849,782USD276
1967-08-26 to 2014-01-31-67,442USD16961
2012-11-01 to 2013-01-31323USD92
2012-05-01 to 2013-01-318,215USD276

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-05-01 to 2014-01-311,767USD276
1967-08-26 to 2014-01-31212,285USD16961
2012-05-01 to 2013-01-31-28,962USD276

Inspect the source

Entity
TENAX THERAPEUTICS, INC. / CIK 0000034956
Captured
2026-09-19T14:46:45.117Z
SEC response SHA-256
3f4f90f5f823d316ffb20bc63506ae090888657f5ff1cb9568439e153f028cf5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000034956.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))